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Available online 07 May 2016Huntington's disease (HD) is an incurable neurodegenerative disorder which causes a triad of motor, cognitive
and psychiatric disturbances. Cognitive disruptions are a core feature of the disease, which signiﬁcantly affect
daily activities and quality of life, therefore cognitive training interventions present an exciting therapeutic inter-
vention possibility for HD. We aimed to determine if speciﬁc cognitive training, in an operant task of attention,
modiﬁes the subsequent behavioural and neuropathological phenotype of the HdhQ111 mouse model of HD.
Three testing groups comprising both HdhQ111 mice and wildtype controls were used. The ﬁrst group received
cognitive training in an operant task of attention at 4months of age. The second group received cognitive training
in a comparable non-attentional operant task at 4 months of age, and the third group were control animals that
did not receive cognitive training. All groupswere then tested in an operant task of attention at 12months of age.
Relative to naïve untrainedmice, both wildtype and HdhQ111mice that received cognitive training in the operant
task of attention demonstrated an increased number of trials initiated, greater accuracy, and fewer ‘time out’ er-
rors. A speciﬁc improvement in response time performance was observed in HdhQ111 mice, relative to naïve un-
trained HdhQ111 mice. Relative to the group that received comparable training in a non-attentional task, both
wildtype and HdhQ111 mice that received attentional training demonstrated superior accuracy in the task and
made fewer ‘time out’ errors. Despite signiﬁcant behavioural change, in both wildtype and HdhQ111 mice that
had received cognitive training, no signiﬁcant changes inneuropathologywere observed between any of the test-
ing groups. These results demonstrate that attentional cognitive training implemented at a young age signiﬁcant-
ly improves attentional performance, at an older age, in both wildtype and HdhQ111 mice. Attentional cognitive
training also improvedmotor performance inHdhQ111mice, thus leading to the conclusion that cognitive training
can improve disease symptoms in a mouse model of HD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Huntington's disease (HD) is caused by a CAG repeat trinucleotide
expansion within the ﬁrst exon of the huntingtin gene (MacDonald
et al., 1993), the disease predominantly affects the medium spiny neu-
rons (MSNs)within the striatum (Reiner et al., 1988) and there are cur-
rently no disease-modifying treatments. HD causes a range of
symptoms including motor, cognitive and psychiatric disturbances
(Diamond et al., 1992; Duff et al., 2007; Paulsen et al., 2008; Tabrizi
et al., 2009),which signiﬁcantly affect daily activities, the ability toman-
age independently and quality of life, even during the early stages of the
disease (Helder et al., 2001; Ready et al., 2008). Cognitive disruptions in
HDhave beenwell documented, and can include speciﬁc problemswith
attention, cognitive ﬂexibility and memory (Butters et al., 1985;
Lawrence et al., 1998a; Lawrence et al., 1999; Lemiere et al., 2004;
Sprengelmeyer et al., 1995). Difﬁculty in sharing attention between. This is an open access article undermore than one task has been demonstrated to be a speciﬁc and core def-
icit in HD (Delval et al., 2008; Thompson et al., 2010). Therefore, cogni-
tive training interventions, which focus on improving executive
function, speciﬁcally focusing on attention, offer a potentially exciting
therapeutic intervention for neurodegenerative diseases including HD.
Previous studies in HD patients (Lawrence et al., 1998a; Lawrence
et al., 1996; Lemiere et al., 2004) and HD knock-in mouse models
(Trueman et al., 2007; Trueman et al., 2012) suggest that problems
with attention are a speciﬁc early deﬁcit within the progression of HD.
Therefore, it may be the case that cognitive training on an attentional
task, at a young age, improves subsequent attentional performance as
the disease progresses. This hypothesis is further supported by human
studies in healthy individuals that suggest repeatedly conducting a
task that requires speciﬁc aspects of executive function can improve
cognitive function as people age (Ball et al., 2002; Willis et al., 2006).
Furthermore, cognitive training studies have been conducted in patients
with other neurodegenerative diseases including Parkinson's disease
(PD) (Milman et al., 2014; París et al., 2011; Sammer et al., 2006;
Sinforiani et al., 2004) and Alzheimer's disease (AD) (Clare et al.,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Hofmann et al., 1996). These studies have demonstrated that cognitive
training, speciﬁcally focused on tasks of executive function, can improve
both cognitive and motor outcomes in PD and AD. However, using cog-
nitive training as a non-pharmacological therapeutic intervention is yet
to be applied to the HD patient population.
Therefore, in this study, ﬁrstly, we aimed to determine if cognitive
training on an automated operant task of attention alters the subse-
quent behavioural or neuropathological phenotype demonstrated by
comparing animals (both wildtype and HdhQ111/+) that had received
attentional cognitive training to naïve animals that had not received
any cognitive training. We also sought to further distinguish the behav-
ioural and neuropathological differences observed between different
types of cognitive training by comparing animals that had received at-
tentional cognitive training (both wildtype and HdhQ111/+) to those
that had received non-attentional cognitive training (both wildtype
and HdhQ111/+). Thus, we aimed to determine the effects of cognitive
training in both wildtype animals and in the HdhQ111 mouse model of
HD prior to further studies to translate the hypothesis into the HD pa-
tient population.
2. Methods
2.1. Animals
HdhQ111/+ knock-in mice (Jax®, Bar Harbour, Maine, U.S.A.) were
bred inhouse on a C57BL/6J background. 21 HdhQ111/+ animals (11 fe-
male, 10 male) and 22 wild type animals (13 female, 9 male) were
used. Animals were genotyped by Laragen Inc. (Culver City, California,
USA), HdhQ111/+ animals contained an average CAG repeat length of
141 (range 134–149 repeats). Animalswere split into three groups, con-
taining both wildtype and HdhQ111/+ mice (Table 1), and kept in a tem-
perature controlled environment (21 °C ± 1 °C) on a 12:12 hour light/
dark cycle (lights on 06.00–18.00). Animals had ad-libitum access to
food, although a water restriction regime was imposed during behav-
ioural testing. Experiments were conducted in accordance with the
2013 European Union Directive 2010/63/EU.
2.2. Operant apparatus
Operant testing was conducted in 16 9-hole operant boxes, con-
trolled by a BehaviourNet Controller BNC MkII operating system
(Campden Instruments, Loughborough, UK). Each operant box
(Fig. 1A) was housed within a sound attenuating chamber, the rear
wall was curved and contained a horizontal array of nine holes
(11 mm diameter, placed 2 mm apart and 15 mm above ﬂoor level).
Each hole contained a photocell infrared beam at the front to detectTable 1
Experimental design of animal testing groups.
*An HdhQ111/+ animal in testing group 3 became ill at approximately 8months of age and
was therefore culled reducing the number of HdhQ111/+ animals in the testing group to 7.
Abbreviation 5-CSRTT = 5-choice serial reaction time task.
Training
(4 months of age)
Testing
(12 months of age)
Group 1
Attentional training
(n = 14, 7 HdhQ111/+)
Nose poke training (15 days)
5-CSRTT training (20 days)
Nose poke training
(15 days)
5-CSRTT testing
(20 days)
Group 2
Non-attentional training
(n = 14, 6 HdhQ111/+)
Nose poke training (15 days)
Extended nose poke training
(20 days)
Nose poke training
(15 days)
5-CSRTT testing
(20 days)
Group 3
Control
(n = 15, 8 HdhQ111/+*)
No training Nose poke training
(15 days)
5-CSRTT testing
(20 days)nose pokes. At the rear, a light emitting device (LED) provided the target
visual stimulus. Only 5 of the 9 holes (termed A, B, C, D and E)were used
in testing; black plastic ﬁlm covers were inserted over unused holes. A
peristaltic pump delivered strawberry milk (Yazoo®, Campina Ltd,
Horsham, UK) to a magazine at the front of the box. Reward delivery
was signalled by an LED above the magazine. Nose pokes into the mag-
azine were detected via an infrared beam.
2.3. Water restriction regime
Oneweek prior to operant training all animals were gradually water
restricted, to a ﬁnal restriction of 3 h of access to water per day, and in-
troduced to Yazoo© strawberry milk reward, in their home cages. Ani-
mals received cognitive training 5 days per week and received daily
access towater 4 h after operant trainingwas completed. Ad-libitum ac-
cess to water was given at weekends.
2.4. Experimental design
All operant training commenced at 4 months of age (Table 1). The
ﬁrst testing group (Group 1) received 15 days of nose poke training,
followed by 20 days of training in the 5-choice serial reaction time
task (5-CSRTT). The second group (Group 2) received a comparable
total number of days (35 days) of nose poke training; however, for the
ﬁnal 20 days an extended nose poke training regime was used, as de-
tailed below. The third testing group (Group 3) were controls and re-
ceived no exposure to, or training in, the operant boxes; however they
were handled and water restricted in the same way as the other testing
groups.
2.5. Nose poke training
At 4months of age, the animals in Groups 1 and 2 (Table 1) received
15 days of nose poke training. Training in responding into themagazine
began with the delivery of 150 μl of strawberry milk into the magazine
and illumination of themagazine light, after successful reward retrieval
the magazine light was extinguished. The process was repeated for the
20 minute session time. Mice were then taught to poke on a simple
ﬁxed-ratio (FR1) schedule of reinforcement. The central hole in the
array was illuminated andmice were required to respond to the stimu-
lus by nose poking. A response to stimulus triggered the light to extin-
guish and the simultaneous illumination of the magazine light and
delivery of 5 μl strawberry milkshake reward. The next trial was initiat-
ed with the illumination of the central light.
2.6. 5 5-CSRTT operant training
After 15 days of nose poke training, Group 1 mice (see Section 2.5
and Table 1) were trained on the 5-CSRTT. Animals were trained to re-
spond to a randomly-presented stimulus light, in order to receive a re-
ward. After a correct response, the light was extinguished, 5 μl of
milkshake reward was delivered, and the magazine light illuminated.
Upon withdrawal from the magazine, the magazine light was
extinguished and the next trial initiated. If a response was not executed
within the stimulus length time, or the subsequent 10 s after the
presentation of the stimulus (termed a ‘limited hold’), the light was
extinguished and a ‘time-out’ period of 10 s was initiated by illumina-
tion of the house light. The process was repeated for the 30minute ses-
sion time. For the ﬁrst 10 days, a 10 s stimulus was presented. A 2 s
stimulus was used for the next 5 days and a 0.5 s stimulus was used
for the ﬁnal 5 days of testing.
2.7. Extended nose poke operant training
In addition to nose poke training, the animals in testing Group 2 re-
ceived 20 days of extended nose poke training. The operant programme
Fig. 1. A. Picture of themouse operant boxes used in behavioural testing. B. Schematic representation of the operant box apparatus, the back responsewall contained 9 stimulus lights, 5 of
whichwere used in operant testing. Holes 1, 3, 5, 7 and 9 contained stimulus lights and photocell detectors to detect nose pokes via breaking of an infrared beam, these correspond to holes
A, B, C, D and E. Holes 2, 4, 6 and 8 were covered with well blanks. Each nose poke contained a stimulus light and an infrared beam to detect nose poke responses.
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poke into, to obtain reward, for the duration of the 30 minute training
session. The location of the response hole differed on subsequent days
of training.
2.8. Operant testing
Operant testing was conducted in all groups at 12 months of age. All
animals were gradually water restricted oneweek prior to operant test-
ing and introduced to strawberry milkshake within their home cages.
All animals were placed on the nose poke training programme, as de-
scribed in Section 2.5. After the completion of training, animals were
tested on the 5-CSRTT.
2.9. Tissue preparation and immunohistochemistry of free ﬂoating sections
Animalswere culled via cervical dislocation, the brainwas post ﬁxed
in 4% paraformaldehyde for 24 h and transferred into 25% sucrose in
phosphate-buffered saline solution. Brains were frozen on a sledge-
microtome (Leitz,Wetzlar), cut into 40 μmcoronal sections, and collect-
ed in 12 parallel series. For immunohistochemistry, 1:12 series of sec-
tions were quenched for 5 min using 10% H2O2 (VWR, West Sussex,
UK) and methanol (Sigma-Aldrich, Dorset, UK). Sections were blocked
in 3% serum in Triton-X and Tris-buffered saline (TxTBS) for 1 h and in-
cubated in a solution of TxTBS, 1% serum and primary antibodies raised
against either DARPP-32 (AB_2314285, Cornell University, 1:30,000
(Ouimet et al., 1984), S830 (a gift from Gillian Bates King's College
London, 1:25,000 (Sathasivam et al., 2001) or Neu-N (Millipore (MAB
377), 1:2000 (Mullen et al., 1992). Incubation in biotinylated-
secondary antibody (1:200) was conducted for 2 h, then sections were
incubated using an ABC kit (Vector Laboratories Ltd, Peterborough,
Cambridgeshire) for 2 h.
Proteins were visualised using 3–3′-diaminobenzadine (DAB), be-
fore mounting on to double-subbed 1% gelatinised slides (Thermo Sci-
entiﬁc, Menzel Gläser). After dehydration and delipidisation in 100%
xylene, slideswere coverslipped usingDPXmountant (Thermo Scientif-
ic, Raymond Lamb, Leicestershire, UK).
For cresyl violet staining a 1:12 series of sectionsweremounted onto
slides and allowed to air dry before incubation for 5 min in: 70% IMS,
95% IMS, 100% IMS, 50/50 chloroform alcohol, 95% IMS, 70% IMS, dis-
tilled water, cresyl violet solution and distilled water. Sections were
dehydrated in 70% and 95% IMS, then destained by agitation in acid al-
cohol solution and coverslipped using DPX mountant.2.10. Stereological analysis
Stereological quantiﬁcation was conducted using Visiopharm Inte-
grator System (VIS, version 4.4.6.9) software on an Olympus Canada
Inc. Q-Imaging Microscope. For each slide, striatal sections were
outlined under an ×1.25 objective lens. Deﬁned striatal areas were
then sampled in a systematically automated fashion and cells were
counted using oil under the ×100 objective lens. The counting frame
size used was 285 μm2. An Abercrombie correction factor was then ap-
plied to the total number of cells counted.
2.11. Statistical analysis
Statistical analyseswere performed in IBMSPSS Statistic 20 software
for windows. Repeated measures ANOVA tests, including the measures
Group, Genotype, Stimulus duration and Hole, followed by simple ef-
fects analysis were conducted. This enabled both the overall effects of
cognitive training and the effects of cognitive training on speciﬁc geno-
types to be established. For histological analyses, univariate ANOVA
tests followed by simple effects analysis were performed.Where signif-
icance was found post-hoc tests with Bonferroni corrections were ap-
plied to identify the locus of effects and their interaction(s). The
signiﬁcance level used throughout was α= 0.05.
3. Results
3.1. Operant training alters the ability to acquire the nose poke response
Animals that received either cognitive training in the attentional op-
erant task (Group 1) or comparable cognitive training in a non-
attentional operant task (Group 2) were able to re-acquire the nose
poke response rapidly, performing approximately 150 responses after
15 days of testing (Fig. 2A). However, the animals that were naive to
the operant boxes (Group 3) took signiﬁcantly longer to acquire the
nose poke response than those that had previously been trained in the
operant boxes (Group: F2,36 = 14.17, p b 0.01). After 15 days of testing
the wildtype animals that were naive to the operant boxes (Group
3) were able to perform comparable levels of responses to HdhQ111/+
animals that had previously received operant training (Groups 1 & 2),
although they were not able to perform as many trials as wildtype ani-
mals that had received operant training. HdhQ111/+ animals that were
naive to the operant boxes were noticeably unable to initiate as many
22 E. Yhnell et al. / Experimental Neurology 282 (2016) 19–26trials as the animals in the other testing groups. Overall HdhQ111/+mice
performed fewer nose pokes than wildtype mice (Fig. 2B; Genotype:
F1,36 = 17.57, p b 0.001), but there was no interaction between geno-
type and group (Genotype × Group; F2,36 = 0.84, p = n.s.).
3.2. Prior operant training in the 5-CSRTT modiﬁes subsequent cognitive
and motor behaviour in the 5-CSRTT
Mice inGroup 1 that received attentional cognitive training on the 5-
CSRTT task at a young age initiated signiﬁcantly more trials in the 5-
CSRTT in comparison to Group 3 animals that had not received prior
cognitive training in the task (Group: F1,23 = 21.83, p b 0.001), as seen
in Fig. 3A. HdhQ111/+ animals overall initiated fewer trials thanwildtype
animals (Fig. 3A, Genotype: F1,23 = 46.58, p b 0.001). Moreover, fewer
trials were initiated when the shorter 0.5 second stimulus length was
used, in comparison to the longer 2 second stimulus length (Fig. 3A,
Stimulus length; F1,23 = 27.75, p b 0.001).
Despite an overall trend for HdhQ111/+ animals to demonstrate a
greater attentional deﬁcit, in response accuracy, than wildtype animals,
this trend failed to meet the threshold for conventional levels of signif-
icance (Fig. 3B, Genotype: F1,23 = 4.21, p = 0.052). Nevertheless, both
wildtype and HdhQ111/+ animals that received prior attentional cogni-
tive training in the 5-CSRTT (Group 1) were signiﬁcantly more accurate
in responding in the 5-CSRTT than naïve animals (Group 3) (Fig. 3B,
Group: F1,23 = 30.86, p b 0.001).
Animals in Group 1, which received attentional cognitive training
demonstrated improved response times in comparison to naïve animals
(Fig. 3C, Group: F1,23= 37.36, p b 0.001). HdhQ111/+ animalswere over-
all signiﬁcantly less accurate than wildtype animals (Fig. 3C, Genotype:
F1,23 = 70.60, p b 0.001). Group 1 HdhQ111/+ animals, that received at-
tentional cognitive training, demonstrated signiﬁcantly faster responseFig. 2.Acquisition of a nose poke response at 12months of age. All animals began the testing ph
boxes all animals began the testing phase with learning the simple nose poke response. Grou
comparable non-attentional cognitive training and Group 3 were naïve control animals. A. A
responses averaged over 15 days of testing. Error bars represent ± standard error of the m
interaction effects were demonstrated. * p b 0.05, ** p b 0.01, *** p b 0.001.times, in comparison to Group 3 HdhQ111/+ animals that were naive
the task (Fig. 3C, Group × Genotype: F1,23= 6.41, p b 0.05). This pattern
of results was also reﬂected in the number of time-outs made in the 5-
CSRTT (Fig. 3D), animals that received attentional cognitive training
made signiﬁcantly fewer time outs in comparison to animals that
were naïve to the task (Fig. 3D, Group; F1,23 = 17.76, p b 0.001).
HdhQ111/+ animalsmade signiﬁcantlymore time-out responses in com-
parison to wildtype animals (Fig. 3D, Genotype: F1,23 = 32.45,
p b 0.001). HdhQ111/+ animals made signiﬁcantly fewer time outs in
the task when they had received attentional cognitive training (Group
1), in comparison to Group 3 HdhQ111/+ animals that were naïve to
the task (Fig. 3D, Group × Genotype; F1,23 = 11.26, p b 0.01).
3.3. Does the operant training require an attentional component to modify
subsequent behaviour in the 5-CSRTT?
Animals that received cognitive training in a non-attentional oper-
ant task (Group 2, Table 1) were able to initiate a similar number of tri-
als in the 5-CSRTT as animals that had received attentional cognitive
training in the 5-CSRTT (Fig. 4A, Group: F1,24 = 3.05, p = n.s.). Overall,
HdhQ111/+ animals initiated fewer trials in the 5-CSRTT than wildtype
animals (Fig. 4A, Genotype: F1,24 = 40.94, p b 0.001) and fewer trials
were initiated for all mice at the shorter 0.5 second stimulus length in
comparison to the 2 second stimulus length (Fig. 4A, Stimulus length:
F1,24 = 21.98, p b 0.001).
Interestingly, Group 1 mice that had received previous attentional
cognitive training were signiﬁcantly more accurate in the 5-CSRTT in
comparison to animals that had received comparable cognitive training
in a non-attentional task (Fig. 4B, Group: F1,24 = 8.84, p b 0.01). Al-
though HdhQ111/+ animals were less accurate overall than wildtype an-
imals (Fig. 4B, Genotype: F1,24 = 18.16, p b 0.001), no signiﬁcantase of the experiment at 12months of age, in order to learn how to response in the operant
p 1 received previous attentional cognitive training in the 5CSRTT. Group 2 had received
cquisition of nose poke responses over 15 days of testing. B. Acquisition of nose pokes
ean. Signiﬁcant results are indicated, Grp = Group, Geno = Genotype, no signiﬁcant
Fig. 3. Attentional cognitive training improves subsequent performance in the 5-CSRTT. A. Total trials started, demonstrated that attentional cognitive training increases the number of
trials started. B. Accuracy in responding was higher in the groups that had received previous training. C. Response time was faster in the groups that had received attentional cognitive
training and signiﬁcantly improved in HdhQ111/+ animals that had received attentional cognitive training. D. Time outs made as a percentage of total responses were decreased in the
group that received attentional cognitive training and signiﬁcantly decreased in HdhQ111/+ animals that had received attentional cognitive training. Data represents a total of 27 animals
(Group 1 n = 14 (7 WT and 7 HdhQ111/+) and group 3, n = 14 (7 WT and 6 HdhQ111/+)). Data is shown for the ﬁnal 5 days of testing at the 2 second and 0.5 second stimulus lengths.
Error bars represent ± standard error of the mean. Signiﬁcant results are indicated, Grp = Group, Geno = Genotype, S.L. = stimulus length. * p b 0.05, ** p b 0.01, *** p b 0.001.
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p = n.s.).
Despite a trend for mice that had received attentional cognitive
training (Group 1) to demonstrate faster response times in the 5-
CSRTT than mice that had received comparable cognitive training in a
non-attentional task (Group 2), this trend failed to meet the threshold
for statistical signiﬁcance (Fig. 4C, Group: F1,24 = 3.61, p = 0.07). Fur-
thermore, animals that received attentional cognitive trainingmade sig-
niﬁcantly fewer time outs in the 5-CSRTT in comparison to animals that
had received comparable cognitive training in a non-attentional task
(Fig. 4D, Group: F1,24 = 13.57, p b 0.05). HdhQ111/+ animals overall
timed out more frequently than wildtype animals (Fig. 4D, Genotype:
F1,24 = 19.84, p b 0.001): despite a trend for HdhQ111/+ animals that
had received attentional cognitive training to make fewer time outs
than HdhQ111/+ animals that had received comparable non-attentional
cognitive training, this interaction failed to meet signiﬁcance (Fig. 4D,
Group × Genotype; F1,24 = 3.73, p = 0.065).
3.4. Does cognitive trainingmodify the associated neuropathology observed
in the HdhQ111/+ mouse model of HD?
Stereological analysis conducted for S830, a marker of mutant
huntingtin inclusions, showed that the number of cells affected by mu-
tant huntingtin inclusions did not differ between HdhQ111/+ animals
that received attentional cognitive training (Group 1) relative to
HdhQ111/+ animals that received non-attentional cognitive training(Group 2) or naïve animals (Group 3) (Group: F2,17 = 1.24, p = n.s.
data not shown). This effect was further reﬂected in cresyl violet, Neu-
N and DARPP-32 cell counts, as no statistically signiﬁcant effect of any
cognitive training regimewas observed between genotypes (cresyl vio-
let: F2,35 = 1.58, p = n.s., Neu-N: F2,33 = 0.13, p = n.s., DARPP-32:
F2,36 = 1.90, p = n.s., data not shown).
4. Discussion
The present study was designed to determine if cognitive training
modiﬁes subsequent behaviour or neuropathology in both wildtype
mice and in the HdhQ111 mouse model of HD. Animals that were given
cognitive training in either an attentional or non-attentional task were
signiﬁcantly faster to reacquire the nose poke response, at 12 months
of age, in comparison to naïve, untrained animals, and this was the
case for both HdhQ111/+ and wildtype animals. Nevertheless all groups
reached stable levels of performance within approximately 15 days of
testing.Moreover, animals that had received attentional cognitive train-
ing in the 5-CSRTT, demonstrated signiﬁcant improvements in all be-
havioural measures of the 5-CSRTT when they were tested at an older
age, and achieved higher levels of asymptotic performance than naïve,
untrained mice. These improvements included: initiating more trials,
making more accurate responses, executing faster responses and mak-
ing signiﬁcantly fewer time outs. Although there was a trend for atten-
tional cognitive training to improve attentional performance in
HdhQ111/+ animals relative to naïve HdhQ111/+ mice, this trend just
Fig. 4. Comparison of attentional and non-attentional cognitive training on subsequent 5-CSRTT performance. A. Total trials started demonstrated less trials were made at the short
stimulus length and by HdhQ111/+ animals in comparison to wildtype animals. B. Accuracy in responding was improved in animals that had received attentional cognitive training in
comparison to animals that had received cognitive training in a non-attentional task. C. Response time was decreased in HdhQ111/+ animals but no effect of cognitive training regime
was seen. D. Time out responses made. Despite a trend for HdhQ111/+ animals that had received attentional cognitive training to make fewer time outs than HdhQ111/+ animals that
had received comparable non-attentional cognitive training, this interaction failed to meet signiﬁcance. The data represents a total of 28 animals (Group 1 contained 14 animals, 7 of
which were HdhQ111/+ and Group 2 contained 14 animals, 6 of which were HdhQ111/+). Error bars represent ± standard error of the mean.
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ed in wildtype animals that had received attentional training relative to
naïve, untrained wildtype animals. However, a speciﬁc beneﬁt of atten-
tional cognitive training was seen in HdhQ111/+ animals, as they
responded signiﬁcantly faster than naïve HdhQ111/+ animals.
Animals that had received attentional cognitive training were more
accurate andmade fewer ‘time out’ responses than animals that had re-
ceived comparable non-attentional cognitive training. There was also a
trend for HdhQ111/+ animals that had received attentional cognitive
training to make fewer time outs than HdhQ111/+ animals that had re-
ceived non-attentional cognitive training, but this trend failed to meet
conventional levels of signiﬁcance. In comparison to animals that had
received attentional cognitive training, non-attentionally trained ani-
mals, initiated the same number of trials and had similar response
times.
While environmental enrichment has previously been used to im-
prove cognitive function in HD mice (Nithianantharajah et al., 2008;
Wood et al., 2010; Wood et al., 2011), using operant cognitive training
to improve cognitive function had only previously been explored in
the zQ175 HD mouse (Curtin et al., 2015). It has previously been dem-
onstrated that cognitive training, at a young age, can attenuate some
of the behavioural deﬁcits observed in zQ175mice. Thus, thepositive ef-
fect of cognitive training, demonstrated in the present study in HdhQ111/
+ mice is supported by this previous study. In comparison to the previ-
ous study (Curtin et al., 2015), the present study has fewer animals and
includes statistical analyses which consider numerous variables in the
analyses, therefore the conclusions drawn can be considered robust.Furthermore, we have conducted further work in the present study,
we have undertaken histological analyses and implemented speciﬁc
cognitive training regimes (attentional and non-attentional) in order
to determine the effects of cognitive training regimes that focused on
different measures of executive function. Furthermore, the results ob-
served are supported by previous studies in patients with other neuro-
degenerative diseases, which have found that cognitive training can
improve both motor and cognitive disease symptoms in PD (Milman
et al., 2014; París et al., 2011; Sammer et al., 2006; Sinforiani et al.,
2004) and AD (Clare et al., 2003; Clare and Woods, 2004; Davis et al.,
2001; Farina et al., 2002; Hofmann et al., 1996).
In the present study, HdhQ111/+ animals that received attentional
cognitive training, were shown to have improved response times in
comparison to naïve animals, this may be reﬂective of an improvement
inmotor function or the ability to initiatemotor function. Both HdhQ111/
+ andwild type animals that had received attentional cognitive training
demonstrated improved attentional ability. These results are particular-
ly relevant to consider with regard to the HD patient population, where
attentional problems have been previously observed (Thompson et al.,
2010). However, these results also have wide reaching implications
for other neurodegenerative diseases and the aging population in gen-
eral, as our study demonstrated that cognitive training, implemented
at a young age, had signiﬁcantly positive behavioural effects inwildtype
mice. Cognitive training has been previously been demonstrated to pre-
vent cognitive decline that would otherwise appear as part of the nor-
mal aging process in both mice (Forster et al., 1996; Gower and
Lamberty, 1993) and humans (Ball et al., 2002; Hanninen et al., 1996;
25E. Yhnell et al. / Experimental Neurology 282 (2016) 19–26Levy, 1994; Persson et al., 2006; Schönknecht et al., 2014; Willis et al.,
2006).
The speciﬁc type of cognitive training regime given to animals is an
important factor in determining efﬁcacy. While cognitive training in an
attentional task at a young age, in the present study, signiﬁcantly
improved attention at an older age, comparable cognitive training in a
non-attentional task did not improve attention at an older age. Thus, the
attentional cognitive training given to animals demonstrated task speciﬁc
improvements in cognitive function. In future iterations of this study it
would be interesting to give attentional cognitive training in the 5-
CSRTT of attention and then later test animals on a different behavioural
task of attention to probe whether the training provides task speciﬁc
beneﬁts or whether the training can cause transfer effects to more
produce general attentional beneﬁts. However, the present study sought
to determine proof of principle and included both attentional and non-
attentional cognitive training to determine any differences in the type of
cognitive training given. In the present study, equivalent motor training
in a non-attentional task demonstrated that animals were able to initiate
as many trials and respond as quickly in the 5-CSRTT as animals that had
received cognitive and motor training in an attentional task. Therefore,
although it can be concluded that the attentional cognitive training
speciﬁcally improved attentional performance at a later age, equivalent
motor training also improved other operant behaviours.
Furthermore, implementing attentional cognitive at a young age, has
the potential to improve HD symptoms, in comparison to animals that
are untrained, aswas demonstrated in the improved response time per-
formance of HdhQ111/+ animals in the 5-CSRTT that received attentional
cognitive training in comparison to naïve animals. This ﬁnding is of
great clinical interest as it demonstrates that the HD brain may demon-
strate a degree of plasticity, particularly if training can be implemented
at a young age. Moreover, environmental enrichment activities such as
exercise (which could be described as motor training) have previously
shown beneﬁt in animals models of HD (Harrison et al., 2013; Hockly
et al., 2002; Pang et al., 2006) and HD patients (Busse et al., 2013;
Busse and Rosser, 2007; Busse et al., 2008; Khalil et al., 2013; Khalil
et al., 2012), although such exercise based therapies can be difﬁcult to
implement in this patient population and can lead to an increased risk
of falls (Busse et al., 2009). Therefore, it may be the case that cognitive
based intervention therapies would have a greater degree of acceptance
and uptake by this patient population.
The 5-CSRTTwas used in this case tomeasure attentional function in
the HdhQ111/+ mouse model of HD. Although attentional deﬁcits have
previously been shown in HD patients (Lawrence et al., 1998a,b),
more speciﬁc difﬁculties in sharing or distributing attention, often
using dual tasks, has been shown to offer a more robust measure of de-
termining attentional dysfunction in HD (Thompson et al., 2010).
Therefore, in future manipulations of this study it may be useful to use
a dual task as a measure of attentional dysfunction may produce even
clearer and more deﬁnitive results.
Finally, immunohistochemical and stereological analyses were
conducted to determine any gross neuropathological changes caused
as a result of the cognitive training regimes. As the cognitive training
intervention was relatively short (35 days), the lack of any signiﬁcant
differences between the numbers of S830 affected cells, cresyl violet,
Neu-N or DARPP-32 stained cells between testing groups is perhaps
unsurprising. However, it is likely that the neuronal connections
underlying the observed behaviours were strengthened as a result of
the cognitive training regimes. For example, molecular changes, such
as increased levels of BDNF expression, have previously been found to
rescue synaptic plasticity and memory in HD mice (Simmons et al.,
2009) and rescue the HDphenotype (Giralt et al., 2011; Xie et al., 2010).
In conclusion, we demonstrate that cognitive training, implemented
at a young age, can modify and improve behavioural symptoms in the
HdhQ111/+ mouse model of HD. The results are of potential clinical sig-
niﬁcance suggesting the possibility that cognitive training may be of
therapeutic beneﬁt for people with HD.Author roles
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